NCT06785987View on ClinicalTrials.gov

Continuous Lidocaine Infusion in Thyroid Surgery Using Intraoperative Neurophysiological Monitoring

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Thyroid DiseaseThyroid SurgeryLidocaine Infusion
Interventions
DRUG

Continuous Lidocaine Infusion

Maintained with sevoflurane and continuous lidocaine infusion under dosage: 1.5 mg/kg/hr

DRUG

intermittent fentanyl infusion

Maintained with volatile anesthetic gas (sevoflurane) and intermittent fentanyl infusion.

DRUG

Continuous remifentanil Infusion

Maintained with sevoflurane and continuous remifentanil infusion under dosage: 3-5μg /kg/hr

Trial Locations (1)

813

Kaohsiung veterans general hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER